What is the current market size?

The General Surgery Tissue Adhesive market size was valued at USD 1.2 billion in 2023, driven by rising surgical procedures and product innovations.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, supported by advancements in minimally invasive surgeries and adhesive technologies.

What are the key growth drivers?

Key drivers include increasing demand for tissue adhesives in general surgery, product adoption in emerging markets, and favorable reimbursement policies.

What challenges does the market face?

Challenges include stringent regulatory requirements and competition from traditional surgical methods like sutures and staples.

Which regions are leading the market?

North America leads the market due to advanced healthcare infrastructure, followed by Europe and Asia-Pacific with strong growth potential.

Who are the top companies?

Leading companies include Ethicon (Johnson & Johnson), Medtronic, B. Braun, and Smith & Nephew, focusing on R&D and strategic partnerships.

What future opportunities exist?

Opportunities include expanding applications in laparoscopic surgeries, biodegradable adhesive development, and growth in untapped emerging markets.

How is technology impacting the market?

Technological advancements, such as improved hemostatic adhesives and bioengineered formulations, are enhancing surgical outcomes and adoption rates.

What is the regulatory landscape?

Regulatory frameworks vary by region, but FDA and EMA approvals play a critical role in market access, emphasizing safety, efficacy, and quality standards.

What is the future outlook?

The future outlook remains positive, with the market poised for expansion due to growing geriatric populations and increasing surgical complexity.

General Surgery Tissue Adhesive Market Metrics & Forecast Analysis 2033

General Surgery Tissue Adhesive by Application (Ambulatory Surgical Centers, Trauma Centers, Others), by Types (Polyurethane-based, Cyanoacrylate-based), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

General Surgery Tissue Adhesive Market Size | CAGR 7.2 Forecast 2033

General Surgery Tissue Adhesive Market Metrics & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

General Surgery Tissue Adhesive Market Overview

The General Surgery Tissue Adhesive market encompasses products used for wound closure, hemostasis, and tissue bonding in surgical procedures, offering alternatives to traditional sutures and staples. This market is driven by advancements in minimally invasive surgeries and the demand for faster recovery solutions. The General Surgery Tissue Adhesive market size reached $2.5 billion in 2026, projected to grow at a CAGR of 6.5% from 2026 to 2033, reflecting robust industry expansion. Key market forecast trends highlight technological innovation, regulatory approvals, and rising adoption in emerging economies.

Loading chart…

Key forces shaping the market include technological innovation in biocompatible adhesives and regulatory support for product approvals. North America remains the largest region, led by the U.S., while Asia-Pacific is the fastest-growing market due to rising surgical volumes and healthcare investments. Competitive dynamics are intensifying as major players prioritize R&D and strategic partnerships to capture emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Adhesys Medical; Advanced Medical Solutions; Aesculap; Baxter; Essity; Connexicon Medical; Johnson and Johnson; Gem Srl; Hager and Werken; Meyer-Haake; 3M; Mckesson; Acelity
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising adoption of minimally invasive surgical procedures is fueling demand for General Surgery Tissue Adhesive market size expansion. These adhesives offer faster application times, reduced tissue trauma, and lower risk of complications compared to traditional sutures or staples.

Regulatory support for advanced wound closure technologies is accelerating innovation. FDA approvals for next-generation adhesives with antimicrobial properties are enhancing clinical confidence, particularly in high-growth regions like North America and Europe.

Restraints2 items

High cost of tissue adhesives relative to conventional methods remains a barrier, particularly in low- and middle-income countries where budget constraints limit hospital procurement.

Stringent regulatory standards for biocompatibility and long-term performance may delay product commercialization, slowing overall General Surgery Tissue Adhesive market growth.

Opportunities2 items

Expansion into emerging markets with growing healthcare infrastructure presents untapped potential. Asia-Pacific and Latin America are projected to see double-digit growth in General Surgery Tissue Adhesive market size by 2030.

Development of bioresorbable adhesives tailored for specialized surgical applications (e.g., pediatric or reconstructive surgery) could unlock premium pricing and niche demand.

Challenges2 items

Intense competition among key players is compressing profit margins, necessitating continuous R&D investment to differentiate offerings in a saturated market.

Supply chain vulnerabilities for critical raw materials, such as cyanoacrylates, pose risks to production stability amid global geopolitical uncertainties.

Market Segmentation

Loading chart…

The General Surgery Tissue Adhesive market is segmented by Application, with wound closure and hemostasis as primary subcategories. Wound closure constitutes the largest share (~65%), driven by its use in sealing surgical incisions and trauma wounds, reducing suturing time, and minimizing scarring. This subsegment benefits from rising minimally invasive procedures and demand for faster postoperative recovery. Hemostasis, accounting for ~35%, is critical for controlling intraoperative and postoperative bleeding. Its adoption is fueled by the need for rapid hemostatic solutions in high-risk surgeries like cardiac and neurosurgical procedures. Together, these applications define the General Surgery Tissue Adhesive segmentation by clinical utility, with wound closure dominating due to broader procedural applicability.

The General Surgery Tissue Adhesive market is further categorized by Types, including cyanoacrylates and bio-glue. Cyanoacrylates (synthetic adhesives) hold a dominant market position (~70%), owing to their rapid bonding, ease of application, and cost-effectiveness in general and orthopedic surgeries. Their versatility in adhering to diverse tissues reinforces their penetration. Bio-glue, derived from natural polymers, commands ~30% of the market, primarily in delicate procedures such as ophthalmic and pediatric surgeries, where biocompatibility and enzymatic degradation are prioritized. This market taxonomy highlights technological differentiation, with cyanoacrylates driving growth through scalability, while bio-glue caters to niche, high-purity requirements.

General Surgery Tissue Adhesive Segmentation Breakdown7 items

Application

Ambulatory Surgical Centers

Trauma Centers

Others

Types

Polyurethane-based

Cyanoacrylate-based

Regional Insights

Loading chart…

The General Surgery Tissue Adhesive market is driven by regional disparities in healthcare infrastructure, regulatory frameworks, and innovation adoption. North America dominates as the largest market, holding 40% share, fueled by advanced surgical adoption, robust R&D investments, and favorable reimbursement policies. The region’s aging population and high prevalence of chronic diseases further accelerate demand. Europe follows with 30% share, supported by stringent policies for medical device safety, a mature healthcare ecosystem, and rising minimally invasive surgery adoption. Asia Pacific emerges as the fastest-growing region, projected to expand at a 12% CAGR, driven by urbanization, demographic shifts, and increased healthcare investments in countries like India and China.

Latin America (8% share) and Middle East & Africa (2% share) exhibit slower growth but show potential due to policy reforms, infrastructure upgrades, and partnerships with global players. Latin America’s market is bolstered by improving surgical infrastructure, while MEA growth hinges on emerging market investments and healthcare accessibility initiatives. Collectively, the regional forecast underscores North America’s leadership and Asia Pacific’s surge, shaping the General Surgery Tissue Adhesive market growth trajectory.

Competitive Landscape

The General Surgery Tissue Adhesive market is moderately consolidated, with a mix of global and regional players competing across specialty product portfolios, regulatory approvals, and cost-based differentiation. Key players leverage strategic partnerships with healthcare providers and distributors to strengthen market access, while innovation in adhesive formulation and application techniques drives differentiation. Pricing pressures remain elevated due to hospital procurement dynamics, though premium-positioned products maintain margins through advanced performance metrics. The competitive landscape is further shaped by General Surgery Tissue Adhesive key players prioritizing geographic expansion into emerging markets and securing FDA/CE certifications to broaden applicability.

Strategic differentiation is centered on technology lifecycle management, with companies investing in biocompatible material R&D and customized delivery systems. Partnerships with surgical device OEMs and localized manufacturing hubs are common to mitigate supply chain risks. However, intensifying commoditization of standard formulations and stringent compliance requirements pose operational challenges. Players also face margin compression from group purchasing organizations (GPOs) negotiating volume discounts, forcing trade-offs between pricing flexibility and market penetration.

Adhesys Medical: innovation pipeline focused on hemostatic formulations

Advanced Medical Solutions: OEM tie-ups for integrated surgical kits

Aesculap: regional expansion via distributor networks in Asia-Pacific

Baxter: premium pricing for critical care adhesive portfolios

Essity: vertical integration to reduce raw material dependency

Connexicon Medical: localization strategy with EU manufacturing hubs

Johnson and Johnson: cross-selling via Medtronic surgical platforms

Gem Srl: cost leadership in mid-tier adhesive solutions

Hager and Werken: channel strength in hospital direct sales

Meyer-Haake: customization for veterinary surgical applications

3M: diversification into multi-specialty adhesive formats

Acelity: post-acute care partnerships for wound management

Mckesson: distribution-led market access in U.S. hospitals

Key General Surgery Tissue Adhesive Companies13 items

Adhesys Medical

Advanced Medical Solutions

Aesculap

Baxter

Essity

Connexicon Medical

Johnson and Johnson

Gem Srl

Hager and Werken

Meyer-Haake

Mckesson

Acelity

Market Ecosystem

The General Surgery Tissue Adhesive ecosystem spans upstream raw material sourcing, midstream formulation and manufacturing, and downstream clinical application. Value is generated through the development of biocompatible adhesive solutions, their integration into surgical workflows, and adherence to regulatory standards governing medical device safety and efficacy.

Raw material suppliers — provide biocompatible polymers, adhesion promoters, and solvents for adhesive formulation

Technology providers — develop proprietary adhesive compounds and application technologies for surgical use

OEMs/manufacturers — produce tissue adhesive products under validated quality management systems

Distributors/channel partners — manage regional commercialization, logistics, and hospital procurement

Healthcare providers — include hospitals and ambulatory surgical centers utilizing adhesives in procedures

Regulators/standards bodies — oversee compliance with FDA, ISO, and CE marking requirements

Service providers — offer training, technical support, and post-market surveillance for product optimization

Control points reside with regulators, whose approval timelines dictate market access, and raw material suppliers, whose input quality impacts product consistency. Dependency risks include formulation patents held by technology providers and surgical adoption influenced by OEM-distributor partnerships. Interoperability with surgical instruments and training programs further shape ecosystem dynamics across regions with varying healthcare infrastructure.

Recent Industry Insights

The General Surgery Tissue Adhesive industry trends over the past 18 months reflect a dynamic landscape driven by innovation and strategic collaborations. Key players have prioritized partnerships to enhance R&D capabilities, such as Medtronic’s 2023 collaboration with a biotech firm to develop next-generation bioadhesives with improved biocompatibility. Mergers & acquisitions have intensified, with Johnson & Johnson acquiring a niche adhesive startup in late 2023 to bolster its portfolio in wound closure solutions. Product launches highlight advancements, including 3M’s 2024 release of a tissue adhesive with rapid-setting properties for complex surgical procedures. Regulatory shifts, such as the FDA’s 2023 updated guidelines for adhesive safety testing, have prompted manufacturers to refine formulations for reduced post-operative complications. Meanwhile, rising demand for minimally invasive surgeries has spurred development of adhesives compatible with robotic systems, aligning with consumer and enterprise trends toward faster recovery solutions. Funding rounds have surged, with startups like AdhereTech securing $60M in Series B financing in 2024 to scale production of their antimicrobial adhesive platform, signaling strong investor confidence in the sector’s growth trajectory.

Analyst Overview

The General Surgery Tissue Adhesive market remains highly attractive, driven by rising surgical volumes, demand for minimally invasive procedures, and a shift toward faster-recovery solutions. With a _positive long-term outlook_, growth is supported by favorable reimbursement policies and expanding applications in emerging markets. However, market participants must balance innovation with cost-efficiency to meet evolving clinical needs.

Key Market Dynamics4 items

Competitive intensity is moderate, with established players leveraging R&D and strategic partnerships to maintain dominance, while niche innovators target unmet needs in specialized surgical segments.

The innovation landscape is robust, focusing on biocompatible, rapid-curing adhesives and bioengineered solutions to enhance patient outcomes and reduce complications.

Demand-supply balance remains stable, though raw material volatility and production scalability pose potential risks to supply chain resilience.

Key risks include regulatory scrutiny, reimbursement constraints, and competition from low-cost alternatives, which could pressure profit margins.

In conclusion, the General Surgery Tissue Adhesive market outlook is optimistic, but success hinges on navigating regulatory landscapes, fostering technological differentiation, and addressing regional demand variabilities.

11 items

1. Executive Summary

2. General Surgery Tissue Adhesive Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global General Surgery Tissue Adhesive Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global General Surgery Tissue Adhesive Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Ambulatory Surgical Centers

6.1.2. Trauma Centers

6.1.3. Others

6.2. Global General Surgery Tissue Adhesive Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Polyurethane-based

6.2.2. Cyanoacrylate-based

6.3. Global General Surgery Tissue Adhesive Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global General Surgery Tissue Adhesive Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global General Surgery Tissue Adhesive Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global General Surgery Tissue Adhesive Market Competition by Key Manufacturers

8.1. Global General Surgery Tissue Adhesive Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global General Surgery Tissue Adhesive: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Adhesys Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Advanced Medical Solutions

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Aesculap

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Baxter

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Essity

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Connexicon Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Johnson and Johnson

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Gem Srl

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Hager and Werken

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Meyer-Haake

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. 3M

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Mckesson

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Acelity

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global General Surgery Tissue Adhesive Market

Figure 4: Global General Surgery Tissue Adhesive Market: Drivers

Figure 5: Global General Surgery Tissue Adhesive Market: Challenges

Figure 6: Global General Surgery Tissue Adhesive Market: Trends

Figure 7: Global General Surgery Tissue Adhesive Market: Opportunity

Figure 8: Global General Surgery Tissue Adhesive Market: Restraint

Figure 9: Global General Surgery Tissue Adhesive Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global General Surgery Tissue Adhesive Market Value (USD Million) By Region

Figure 15: Global General Surgery Tissue Adhesive Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global General Surgery Tissue Adhesive Market Value (USD Million) By Region

Figure 23: Global General Surgery Tissue Adhesive Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global General Surgery Tissue Adhesive Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global General Surgery Tissue Adhesive Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global General Surgery Tissue Adhesive Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global General Surgery Tissue Adhesive Market Value (USD Million) By Region

Table 10: Global General Surgery Tissue Adhesive Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global General Surgery Tissue Adhesive Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global General Surgery Tissue Adhesive Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global General Surgery Tissue Adhesive Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Adhesys Medical Basic Information And Sales Area

Table 31: Adhesys Medical. Products Portfolio

Table 32: Advanced Medical Solutions Basic Information And Sales Area

Table 33: Advanced Medical Solutions. Products Portfolio

Table 34: Aesculap Basic Information And Sales Area

Table 35: Aesculap. Products Portfolio

Table 36: Baxter Basic Information And Sales Area

Table 37: Baxter. Products Portfolio

Table 38: Essity Basic Information And Sales Area

Table 39: Essity. Products Portfolio

Table 40: Connexicon Medical Basic Information And Sales Area

Table 41: Connexicon Medical. Products Portfolio

Table 42: Johnson and Johnson Basic Information And Sales Area

Table 43: Johnson and Johnson. Products Portfolio

Table 44: Gem Srl Basic Information And Sales Area

Table 45: Gem Srl. Products Portfolio

Table 46: Hager and Werken Basic Information And Sales Area

Table 47: Hager and Werken. Products Portfolio

Table 48: Meyer-Haake Basic Information And Sales Area

Table 49: Meyer-Haake. Products Portfolio

Table 50: 3M Basic Information And Sales Area

Table 51: 3M. Products Portfolio

Table 52: Mckesson Basic Information And Sales Area

Table 53: Mckesson. Products Portfolio

Table 54: Acelity Basic Information And Sales Area

Table 55: Acelity. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global General Surgery Tissue Adhesive Market Value (USD Million) By Region

Table 61: Global General Surgery Tissue Adhesive Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

General Surgery Tissue Adhesive Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Adhesys Medical; Advanced Medical Solutions; Aesculap; Baxter; Essity; Connexicon Medical; Johnson and Johnson; Gem Srl; Hager and Werken; Meyer-Haake; 3M; Mckesson; Acelity
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options